Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
No Prevention, No End: AVAC Report 2018

In just about 24 months, the world will arrive at the deadline for the UNAIDS "Fast Track" goals for ending the epidemic. The primary fast-track goal for HIV prevention is reduction in new diagnoses from roughly 2,000,000 a year, to less than 500,000. There's no chance this goal will be achieved.

Published
18 hours ago
From
AVAC
A Blue Pill Is Stopping HIV, World-First Study Shows

An antiviral pill taken daily by thousands of men across Sydney and other parts of Australia led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.

Published
23 hours ago
From
Bloomberg
My PrEP Story: Will

As the IMPACT Trial hits its first anniversary, PrEPster co-founder Will Nutland says that the waiting needs to stop: full implementation of PrEP must become a priority.

Published
12 October 2018
From
Prepster
Study reveals racial differences in HIV prevention method use

Black women report higher levels of medical mistrust — hindering their access to an important HIV prevention medication — according to a new study published by researchers at the Yale School of Public Health and George Washington University.

Published
09 October 2018
From
Yale Daily News (blog)
HIV prevention drug PrEP to be evaluated for State funding

Health authorities have begun a formal process to evaluate the possibility of introducing a State-funded HIV prevention drug.

Published
08 October 2018
From
Irish Times
First U.S. Failure of Truvada as PrEP Is Reported at IDWeek

A poster presentation at IDWeek, a yearly conference held by the Infectious Diseases Society of America, revealed that a 21-year-old Latinx man has acquired HIV despite consistently high adherence to pre-exposure prophylaxis (PrEP). This new report is unique for several reasons, primarily because this is the first known HIV seroconversion with verified adherence to PrEP in the U.S.

Published
07 October 2018
From
The Body Pro
Making Clinical Trials of PrEP More Inclusive of Women, No Matter Their Pregnancy Status

Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?

Published
01 October 2018
From
The Body Pro
My PrEP Story: P

How did P Masters remember to take his PrEP? Find out in his My PrEP Story blog along with why a sexual partners’ HIV status no longer matters to him. My PrEP Story is the personal voice of people who are using, or have used, PrEP. Find out more about their decisions to use PrEP, how they have navigated using PrEP, and their very own PrEP journey.

Published
24 September 2018
From
PrEPster
My PrEP Story: KUCHENGA

The majority of KUCHENGA’s sexual partners are straight. In her first My PrEP Story blog, KUCHENGA says it’s trans women who are educating straight men about PrEP. My PrEP Story is the personal voice of people who are using, or have used, PrEP. Find out more about their decisions to use PrEP, how they have navigated using PrEP, and their very own PrEP journey.

Published
24 September 2018
From
Prepster
PrEP drug patent overturned in UK - NAT respond

The High Court has today overturned Gilead's patent extension on Truvada, the HIV drug also used in PrEP.

Published
18 September 2018
From
National AIDS Trust
← First12345...115Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.